top of page
Double IHC2.png

OCMF 2023

Access the 2023 Conference recording on VuMedi

Download the 2023 Agenda

Distinguished Keynote Speakers

belcher.jpg

Angela Belcher, PhD

Topic: Developing Tools to Detect Millimeter and Sub-millimeter Ovarian and Fallopian Tumors-Towards Early Detection and Interception of Ovarian Cancer

Institute for Integrative Cancer Research

George Coukos, MD, PhD

Topic: Advancing Immunotherapy in Ovarian Cancer

University of Lausanne

COUKOS-George.png

2023 Speakers

Developing Tools to Detect Millimeter and Sub-millimeter Ovarian and Fallopian Tumors-Towards Early Detection and Interception of Ovarian Cancer Featured Keynote: Angela Belcher, PhD Koch Institute for Integrative Cancer Research The Role Of The Extracellular Matrix In Ovarian Cancer Sandra Orsulic, PhD University of California, Los Angeles Housing temperature as a new model for studying the impact of chronic adrenergic stress on tumor growth and anti-tumor immunity Elizabeth Repasky, PhD Roswell Park Comprehensive Cancer Center Molecular Mechanisms Which Regulate Fitness Fingerprints Between Cancer and its Microenvironment Esha Madan, PhD Virginia Commonwealth University The DOD OCRP Ovarian Cancer Academy: Early Career Investigators Making a Difference in Ovarian Cancer Research Kenneth Nephew, PhD Indiana University CDON: A potential therapeutic vulnerability in ovarian cancer Denise Connolly, PhD Fox Chase Cancer Center Combining DNA methyltransferase inhibitors with platinum as a strategy to prevent recurrent ovarian cancer Heather O'Hagan, PhD Indiana University Targeting mitochondrial vulnerabilities for cancer therapy Evripidis Gavathiotis, PhD Albert Einstein College of Medicine Intra-Tumoral Nerves in Immunosurveillance Sebastien Talbot, PhD Queen’s University, Ontario Beyond Darwin: Understanding Cancer Persister Cells Yaara Oren, PhD School of Medicine, Tel Aviv University Cytomegalovirus (CMV) and Patient-Reported Outcomes in Ovarian Cancer Rachel Vogel, PhD University of Minnesota

Advancing Immunotherapy in Ovarian Cancer Featured Keynote: George Coukos, MD, PhD University of Lausanne Tubal Immune Milieu and Tumor Precursor Evolution in the Development of High-Grade Serous Carcinoma Thing Soong, MD, PhD University of Pittsburgh Susceptibility Genes in the Less Common Histotypes of Epithelial Ovarian Cancer Susan Ramus, PhD University of New South Wales Engineered Bacteria for Cancer Therapy Tal Danino, PhD Columbia University Replication Driven Vulnerabilities In Cyclin E Overexpressing Ovarian Cancers Priyanka Verma, PhD Washington University, School of Medicine Role of ZNF217 in Ovarian Cancer Metastasis Achuth Padmanabhan, PhD University of Maryland, Baltimore County Progesterone: Ovarian and Breast Cancer in BRCA1 Carriers Jaeyeon Kim, DVM, PhD, MS Indiana University, School of Medicine Targeting immune vulnerabilities and heterogeneity in ovarian cancer Dmitriy Zamarin, MD, PhD Tisch Cancer Institute, Icahn School of Medicine, Mount Sinai Targeting the Damaged Transcriptome as an Emergent Vulnerability in Ovarian Cancer Robert Rottapel, MD University of Toronto Novel ADC’s in Ovarian Cancer Stephanie Lheureux, MD, PhD UNH Toronto Combinatorial Therapies For Ovarian Cancer Treatment Joyce Liu, MD, MPH Dana Farber Cancer Institute

Photos

bottom of page